The Global Exocrine Pancreatic Insufficiency (EPI) Market is estimated to grow at a CAGR of around 7.2% during the forecast period, i.e., 2024-30.
Global Exocrine Pancreatic Insufficiency (EPI) Market Driver:
Rising Incidences of Pancreatic Disorders Escalating the Demand – In recent years, there has been a surge in patients suffering from cystic fibrosis and other pancreatic disorders due to genetic predispositions & other lifestyle factors. These health-related concerns result in the shortage of the exocrine leading to digestion issues. Therefore, to eradicate these health issues, customers across the globe are pursuing solutions that help to fulfill the nutritive needs of the body.
Similarly, the individuals are also suffering from pancreatic cancer, which mainly concerns the pancreas of the individual. For instance, according to the Global Cancer Observatory, worldwide in 2022 there were about 511 thousand new cases of pancreatic cancer and by 2045 it will increase to 911 thousand.
Therefore, the inhabitants suffering from these deadly cancers require immediate medical intervention and undergo treatments that offer smooth functioning of the vital body organs. Further, the investigation conducted by several research associations states that the number of individuals suffering from pancreatic cancer would continue to rise. Consequently, this would further accelerate the need for different treatment options available, thereby driving the overall market for Exocrine Pancreatic Insufficiency.
Download a free sample copy of the Report: https://www.marknteladvisors.com/query/request-sample/exocrine-pancreatic-insufficiency-market.html
Key Market Reports Highlights
- Market Dimensions & Projections
- Pricing Evaluation
- Recent Strategic Moves by Companies
- Primary Stakeholders
- Import/Export Trend Analysis
- Competitive Landscape Assessment
- Emerging Opportunities
- Market Trends and Indicators
*Reports Delivery Format – Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.
Browse Full Report including (TOC+ List of Table and Figures): https://www.marknteladvisors.com/research-library/exocrine-pancreatic-insufficiency-market.html
Global Exocrine Pancreatic Insufficiency (EPI) Market Segmentation:
The market report categorizes the market based on different segments and geographical analysis.
Study Timeline:
-Base Year: 2023
-Historical Period: 2019 to 2022
-Forecast Period: 2024 to 2030
- By Treatment Method
- Pancreatic Exocrine Replacement Therapies (PERT)- Market Size & Forecast 2019-2030, USD Million
- Nutritional Therapy- Market Size & Forecast 2019-2030, USD Million
- By Distribution Channel
- Hospital Pharmacies- Market Size & Forecast 2019-2030, USD Million
- Retail Pharmacies- Market Size & Forecast 2019-2030, USD Million
- Online Pharmacies- Market Size & Forecast 2019-2030, USD Million
- By Region
- North America
- South America
- Europe
- The Middle East & Africa
- Asia-Pacific
Competitive Landscape
With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading market companies, including – AbbVie Inc ., Nestlé, Digestive Care, Inc., Alcresta Therapeutics, Inc., Organon Group of Companies, Vivus LLC, and Others
Have questions? Our consultant is ready to assist: https://www.marknteladvisors.com/query/talk-to-our-consultant/exocrine-pancreatic-insufficiency-market.html
We follow a tried-and-tested research methodology that blends top-down and bottom-up approaches to deliver highly accurate market insights. Every report is powered by data triangulation, ensuring well-rounded and validated findings.
From smart sample selection and reliable data collection to in-depth analysis and precise forecasting, our process is designed to minimize error and maximize impact.
About Us –
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.
Contact Us
MarkNtel Advisors
Email: sales@marknteladvisors.com
Website: www.marknteladvisors.com
Latest Press Release – https://www.marknteladvisors.com/press-release
